TITLE

EFICIENÈšA TERAPIEI ADJUVANTE CU FACTORUL VIIA RECOMBINAT ÃŽN HEMORAGIILE SEVERE DUPÄ‚ CHIRURGIA NEOPLASMULUI RECTAL

PUB. DATE
July 2010
SOURCE
Jurnalul de Chirurgie;2010, Vol. 6 Issue 3, p317
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
56642057

 

Related Articles

  • Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial. Frilling, Andrea; Stavrou, Gregor A.; Mischinger, Hans-Jörg; de Hemptinne, Bernard; Rokkjaer, Mogens; Klempnauer, Jürgen; Thörne, Anders; Gloor, Beat; Beckebaum, Susanne; Ghaffar, Mohamed F. A.; Broelsch, Christoph E. // Langenbeck's Archives of Surgery;Apr2005, Vol. 390 Issue 2, p114 

    Background and aims: A new carrier-bound fibrin sealant, TachoSil, is expected to be efficacious and safe as a haemostatic treatment in hepatic resection. Design: A prospective, randomised, open and controlled multicentre trial with in- traoperative as well as postoperative assessment of...

  • A Guide to Disorders of Hemostasis. Goulian, Mehran // Annals of Internal Medicine;Oct66, Vol. 65 Issue 4, p782 

    Presents a guide for the diagnosis and treatment of hemostasis disorders. Areas of hemostatic mechanisms; Hypothetical scheme for mechanism of blood coagulation; Classification of hemostasis disorders.

  • Anterior resection with total mesorectal excision. Steele, R.J.C. // Journal of the Royal College of Surgeons of Edinburgh;Feb99, Vol. 44 Issue 1, p40 

    Describes how the author performs anterior resection with total mesorectal excision. Two main drawbacks of the procedure which is the standard treatment of cancer of the rectum; Adequate exposure; Identification of the hypogastric nerves; Full mobilization of the left colon; Meticulous...

  • ReFacto.  // Royal Society of Medicine: Medicines;2002, p470 

    This article presents information on ReFacto, a proprietary, prescription-only preparation of factor VIII fraction (octocog alfa), which acts as hemostatic drug to reduce or stop bleeding in the treatment of disorders in which bleeding is prolonged and potentially dangerous (mainly hemophilia...

  • Recombinant Activated Factor VII: Current Perspectives and Epworth Experience Labattaglia, Matthew P.; Ihle, Benno // Heart, Lung & Circulation;Jun2007 Supplement 3, Vol. 16 Issue s3, pS96 

    Recombinant factor VII was first developed for control and prevention of bleeding in haemophilia with antibodies to factor VIII and IX. Its efficacy in these situations is well established. Over recent years, the ‘off-label’ use of this substance has become more widespread in...

  • hemorrhoidectomy.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1056 

    A definition of the medical term "hemorrhoidectomy," which refers to the excision or destruction of hemorrhoids by one of several techniques, is presented.

  • LATE TOXICITY FOLLOWING SHORT COURSE PREOPERATIVE RADIOTHERAPY FOR OPERABLE RECTAL CANCER. King, M.; Tolan, S.; Giridharan, S.; McConkey, C.; Hartley, A.; Geh, J.I. // Gut;Apr2003 Supplement 1, Vol. 52, pA90 

    Introduction: Short course preoperative radiotherapy (SCPRT) reduces local recurrence following total mesorectal excision (TME). In the Dutch TME trial the absolute reduction was 5.8% at 2 years (2.4% vs. 8.2%). This benefit should be weighed against acute and late side effects following...

  • Coagulation activation and changes during treatment of acute myeloid leukaemia: A prospective cohort study. Nilsson, Gunnar; Jan, Astermark; Karin, Strandberg; Stina, Wichert; Bengt, Sallerfors; Erik, Berntorp // Journal of Hematological Malignancies;Jun2012, Vol. 2 Issue 2, p11 

    Objective: Many patients with malignancies demonstrate coagulation abnormalities as activated coagulation and activation of fibrinolysis. Chemotherapy used for the treatment of leukemia may influence the coagulation changes. The purpose of this study was to examine hematological changes in...

  • Good or Poor Responses of Hemostatic Molecular Markers in Patients with Hematopoietic Disorders After Treatment of Disseminated Intravascular Coagulation. Watanabe, Rika; Wada, Hideo; Yamamuro, Miho; Inoue, Akiko; Watanabe, Masato; Kumeda, Kousuke; Sakakura, Miho; Okugawa, Yoshinaga; Nakasaki, Takahiro; Deguchi, Hiroshi; Gabazza, Esteban C.; Mori, Yoshitaka; Nishikawa, Masakatsu; Nobori, Tutomu; Shiku, Hiroshi // Clinical & Applied Thrombosis/Hemostasis;Jan2003, Vol. 9 Issue 1, p71 

    Changes of hemostatic markers in 226 patients with disseminated intravascular coagulation (DIC) and hematopoietic disorders were examined after treatment of DIC. The changes in prothrombin time (PT) ratio, fibrinogen, fibrin and fibrinogen degradation products (FDP), antithrombin, and protein C,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics